CBS siRNA knockdown or AOAA treatment of the CBS-expressing ovarian cancer cells lines resulted in a significant suppression of cell proliferation (measured by 3H-thymine incorporation) and a lowered viability. Here, CBS is linked to ovarian carcinoma.